Avience Biomedicals share news, announcements and annual reports
NSE: AVIENCEHealthcare Equipment & Supplies
Share price at the NSE close on 28 Oct 2026. Previous close ₹258.00.
28 Oct: open ₹264.40, high ₹270.90, low ₹264.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹148 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.96
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Jun 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 27.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.92
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,80056.5% delivered
Avience Biomedicals has 18 announcements on record, routine notices left out; 4 in the 30 days to 29 Oct 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Avience Biomedicals half-yearly results
The board met on 25 Aug 2026 to consider financial results and other business matters
Notice filed 20 Aug 2026
Avience Biomedicals annual reports, presentations and earnings calls
The company's own documents, latest first.Avience Biomedicals financials, year by year
Annual reports1
- Annual report, year to Mar 20268 Sep 2026
Investor presentations1
- Investor Presentation24 Jul 2026
Earnings calls2
- Transcript28 Jul 2026
- Link of Recording of con. call held as on 24.07.202625 Jul 2026
Avience Biomedicals share news and announcements
Newest first.
Oct 2026
1 Oct · Analysts
Sep 2026
30 Sep · Management
30 Sep · Meeting
23 Sep · Analysts
16 Sep · Updates
7 Sep · Board meeting
Aug 2026
26 Aug · Results
Jul 2026
17 Jul · Results
14 Jul · Board meeting
13 Jul · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 17 Jul 2026Resultsdown 19.69%−20.1 pts vs Nifty 500market median −0.7% · five sessions −9.5% (−8.4 pts vs Nifty 500) · The announcement
Avience Biomedicals results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Assets turning to cash within a year | At Mar 2026 | Consolidated | 46.54 | 43.16 | −7.3% | 17 Jul 2026 | 26 Aug 2026 |
| Total assets | At Mar 2026 | Consolidated | 77.94 | 74.57 | −4.3% | 17 Jul 2026 | 26 Aug 2026 |
| Other liabilities due within a year | At Mar 2026 | Consolidated | 4.43 | 1.05 | −76.2% | 17 Jul 2026 | 26 Aug 2026 |
| Liabilities due within a year | At Mar 2026 | Consolidated | 32.96 | 29.58 | −10.2% | 17 Jul 2026 | 26 Aug 2026 |
| Total equity and liabilities | At Mar 2026 | Consolidated | 77.94 | 74.57 | −4.3% | 17 Jul 2026 | 26 Aug 2026 |
| Change in other current assets | Year to Mar 2026 | Consolidated | −1.80 | 1.58 | +187.8% | 17 Jul 2026 | 26 Aug 2026 |
| Change in other current liabilities | Year to Mar 2026 | Consolidated | 1.33 | −2.05 | −254.2% | 17 Jul 2026 | 26 Aug 2026 |
| Items whose cash is in investing or financing | Year to Mar 2026 | Consolidated | 1.35 | −0.08 | −105.8% | 17 Jul 2026 | 26 Aug 2026 |
| Adjustments from profit to cash | Year to Mar 2026 | Consolidated | −3.69 | −3.69 | 0.0% | 17 Jul 2026 | 26 Aug 2026 |
| Cash generated before tax | Year to Mar 2026 | Consolidated | 8.78 | 8.78 | 0.0% | 17 Jul 2026 | 26 Aug 2026 |